Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Journal of Medicinal Chemistry
|
March 3, 2026
The Biggest Challenge for Prediction of Membrane Permeability of Cyclic Peptides: Scarce Data Availability
Christina Lamers
ACS Pharmacology & Translational Science
|
August 14, 2025
Crossing Barriers: Advancements in Macromolecular Therapeutics for Neurodegenerative Diseases and Strategies to Overcome the Blood-Brain Barrier
Bekas Alo, Christina Lamers
RSC Medicinal Chemistry
|
August 27, 2021
Macrocyclization strategies for cyclic peptides and peptidomimetics
Clément Bechtler, Christina Lamers
Pharmazie in Unserer Zeit
|
February 3, 2012
[Success in the elucidation of receptor structure: medicinal chemistry of β (2)-agonists]
Christina Lamers, Manfred Schubert-Zsilavecz
Expert Opinion on Therapeutic Patents
|
June 16, 2012
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
American Journal of Hematology
|
February 9, 2023
Complement-targeted therapeutics: An emerging field enabled by academic drug discovery
Christina Lamers, Daniel Ricklin, John D Lambris
Current Topics in Medicinal Chemistry
|
November 13, 2014
Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Frontiers in Immunology
|
May 17, 2021
The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology
Christina Lamers, Carla Johanna Plüss, Daniel Ricklin
Chimia
|
July 8, 2021
Therapeutic Peptides as Emerging Options to Restore Misguided Host Defence and Homeostasis: From Teaching to Concept to Clinic
Oliver Schwardt, Christina Lamers, Clément Bechtler, et al.
Expert Opinion on Therapeutic Patents
|
January 8, 2013
Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012)
Daniel Flesch, Daniel Merk, Christina Lamers, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Journal of Medicinal Chemistry
|
March 3, 2026
The Biggest Challenge for Prediction of Membrane Permeability of Cyclic Peptides: Scarce Data Availability
Christina Lamers
ACS Pharmacology & Translational Science
|
August 14, 2025
Crossing Barriers: Advancements in Macromolecular Therapeutics for Neurodegenerative Diseases and Strategies to Overcome the Blood-Brain Barrier
Bekas Alo, Christina Lamers
RSC Medicinal Chemistry
|
August 27, 2021
Macrocyclization strategies for cyclic peptides and peptidomimetics
Clément Bechtler, Christina Lamers
Pharmazie in Unserer Zeit
|
February 3, 2012
[Success in the elucidation of receptor structure: medicinal chemistry of β (2)-agonists]
Christina Lamers, Manfred Schubert-Zsilavecz
Expert Opinion on Therapeutic Patents
|
June 16, 2012
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
American Journal of Hematology
|
February 9, 2023
Complement-targeted therapeutics: An emerging field enabled by academic drug discovery
Christina Lamers, Daniel Ricklin, John D Lambris
Current Topics in Medicinal Chemistry
|
November 13, 2014
Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists
Christina Lamers, Manfred Schubert-Zsilavecz, Daniel Merk
Frontiers in Immunology
|
May 17, 2021
The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology
Christina Lamers, Carla Johanna Plüss, Daniel Ricklin
Chimia
|
July 8, 2021
Therapeutic Peptides as Emerging Options to Restore Misguided Host Defence and Homeostasis: From Teaching to Concept to Clinic
Oliver Schwardt, Christina Lamers, Clément Bechtler, et al.
Expert Opinion on Therapeutic Patents
|
January 8, 2013
Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012)
Daniel Flesch, Daniel Merk, Christina Lamers, et al.
Page
of 4